Sign In
Buy INBS
$2.44
-0.100 (-3.94%)
At Close: Jun 03, 2026
Intelligent Bio Solutions to Present PK Study Data at Association for Diagnostics and Laboratory Medicine 2025 Clinical Lab Expo
08:30am, Thursday, 10'th Jul 2025
Data shows excretion of codeine in fingerprint sweat INBS' System is viable option for non-invasive diagnostic testing NEW YORK, July 10, 2025 (GLOBE NEWSWIRE) -- Intelligent Bio Solutions Inc. (Nasd
Intelligent Bio Solutions and Spjotgard Drive Rapid Adoption of Fingerprint Drug Testing Across Scandinavia
08:30am, Wednesday, 25'th Jun 2025
With over 450 accounts across 24 countries, INBS continues to advance the evolution of drug screening technology With over 450 accounts across 24 countries, INBS continues to advance the evolution of
NEW YORK, June 18, 2025 (GLOBE NEWSWIRE) -- Intelligent Bio Solutions Inc. (Nasdaq: INBS) (“INBS” or the “Company”), a medical technology company delivering intelligent, rapid, non-invasive te
INBS Stock May Rise on SMARTOX Partnership Expanding Forensic Reach
12:16pm, Monday, 16'th Jun 2025
Intelligent Bio Solutions collaborates with SMARTOX to expand U.S. forensic reach, boosting its drug test tech and eyeing FDA clearance for growth.
Intelligent Bio Solutions Expands U.S. Forensic Market Presence, Seeks FDA Clearance for Breakthrough Fingerprint Drug Testing
08:30am, Wednesday, 11'th Jun 2025
SMARTOX has deployed over 50 of INBS' Intelligent Fingerprinting Drug Screening Readers and facilitated over 7,000 screening tests, including more than 1,500 tests in 2024 alone
INBS to participate with U.S. distribution partner SMARTOX at RISE25, the leading U.S. conference on addiction, mental health, and justice innovation which draws over 7,000 attendees annually
Intelligent Bio Solutions Showcases Rapid, Non-Invasive Drug Testing Capabilities in Remote Queensland Workforce Deployment
08:30am, Monday, 19'th May 2025
Completion of 160 tests conducted in less than 90 minutes demonstrates a level of speed and efficiency beyond the limits of traditional testing approaches Completion of 160 tests conducted in less tha
Intelligent Bio Solutions Accelerates Global Adoption of Fingerprint Drug Testing
09:00am, Thursday, 15'th May 2025
Company surpasses 450 accounts across 24 countries as global demand for fingerprint drug testing surges Company surpasses 450 accounts across 24 countries as global demand for fingerprint drug testing
Intelligent Bio Solutions Announces Fiscal Q3 2025 Financial Results and Key Operational Achievements
08:30am, Tuesday, 13'th May 2025
20% sequential quarterly revenue growth and 91% year-over-year quarterly gross profit growth Continued momentum from recurring higher-margin cartridge sales now reaching 58% of total sales for the nin
Intelligent Bio Solutions Drives Global Growth Through Multilingual Digital Expansion
08:30am, Tuesday, 06'th May 2025
Arabic, Italian, and Spanish-language websites unlock commercial access to regions representing over 1.4 billion people Multilingual rollout aligns with product readiness and accelerates international
Intelligent Bio Solutions Expands Global Reach with Latin American Spanish Language Integration into Drug Screening System
08:30am, Tuesday, 22'nd Apr 2025
Company expands Intelligent Fingerprinting Drug Screening System multilingual capabilities to meet growing demand across Latin American Spanish-speaking markets
Intelligent Bio Solutions Expands Middle East Market Reach with Arabic Integration in Drug Screening System
08:30am, Monday, 31'st Mar 2025
NEW YORK, March 31, 2025 (GLOBE NEWSWIRE) -- Intelligent Bio Solutions Inc. (Nasdaq: INBS) (“INBS” or the “Company”), a medical technology company delivering intelligent, rapid, non-invasive t
Intelligent Bio Solutions to Highlight Proprietary Drug Testing Technology at 2025 NDASA Conference and Trade Show
08:30am, Friday, 28'th Mar 2025
NEW YORK, March 28, 2025 (GLOBE NEWSWIRE) -- Intelligent Bio Solutions Inc. (Nasdaq: INBS) ("INBS" or the "Company"), a medical technology company delivering intelligent, rapid, non-invasive testing
Intelligent Bio Solutions Stock Drops Despite Key U.S. Patent Win
11:50am, Thursday, 27'th Mar 2025
INBS secures a key U.S. patent, strengthening its IP protection and paving the way for 2025 market entry with innovative biometric technology.
Intelligent Bio Solutions Highlights Continued Expansion with Strategic Partnership in Spain and Andorra
09:00am, Thursday, 27'th Mar 2025
INBS set to capitalize on growing Spanish Drug Testing Market, anticipated to reach $448 million by 2030 Major Spanish accounts currently require 1,000 drug testing cartridges per month NEW YORK, Marc
